SCHEMBL8686454

SCHEMBL8686454

c1csc(-c2cnn3cc[nH]c23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 1/20 0.39
TDO2 P48775 1/20 0.37
CDK8 P49336 1/20 0.35
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
RXFP1 Q9HBX9 1/20 0.35
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 4/20 0.35
HSD17B10 Q99714 3/20 0.35
POLB P06746 2/20 0.35
CHEK1 O14757 2/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2E1 P05181 1/20 0.34
CYP2A6 P11509 1/20 0.34
CYP2B6 P20813 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MAPT P10636 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15261212 0.78 PLAT (0.53) PLATTDO2MEN1KMT2ANPC1
SCHEMBL9591318 0.70 IDO1 (0.37) CDK8MEN1KMT2ANPC1RAB9A
SCHEMBL8684075 0.70 ALDH1A1 (0.39) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL8685785 0.70 KDM4E (0.43) MEN1KMT2ANPC1RAB9ARXFP1
SCHEMBL24147766 0.67 PIK3CA (0.46) TDO2MEN1KMT2ANPC1RAB9A
SCHEMBL4881184 0.67 PIM1 (0.39) TDO2MEN1KMT2ANPC1RAB9A
SCHEMBL8684135 0.66 PARP1 (0.45) PLATMEN1KMT2ANPC1RAB9A
SCHEMBL21233347 0.64 KDM4E (0.43) TDO2MEN1KMT2ANPC1RAB9A
SCHEMBL10650146 0.63 NPC1 (0.38) TDO2MEN1KMT2ANPC1RAB9A
SCHEMBL9301003 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5723481-A ANTIULCER AGENTS AND 5-LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-03-03 US claimed
US-5354768-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY, LIMITED (JP) 1994-10-11 US claimed
EP-0353047-B1 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO CO (JP) 1994-10-05 EP claimed
EP-0353047-A2 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents Sankyo Company Limited (JP) 1990-01-31 EP claimed
US-5723481-A ANTIULCER AGENTS AND 5-LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-03-03 US disclosed
US-5698576-A POSSESS ANTI-ULCER AND 5-LIPOXYGENASE INHIBITORY ACTIVITIES SANKYO COMPANY, LIMITED (JP) 1997-12-16 US disclosed
US-5665752-A LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1997-09-09 US disclosed
US-5354768-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY, LIMITED (JP) 1994-10-11 US disclosed
EP-0353047-B1 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO CO (JP) 1994-10-05 EP disclosed
US-5232939-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY LIMITED (JP) 1993-08-03 US disclosed
EP-0353047-A2 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents Sankyo Company Limited (JP) 1990-01-31 EP disclosed